Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Molecular Diagnostics: Page 2
NGeneBio, Genolution to collaborate on automated NGS system
By
LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Gene-based technique shows potential for rapid diagnostics
By
LabPulse.com staff writers
Biomedical engineers have developed a new gene-based approach which can be used on test strips for rapid, on-the-spot disease detection with accuracy comparable to that of lab-based polymerase chain reaction (PCR) tests.
March 7, 2024
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By
LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Reversible, multiplex CRISPR system enhances efficacy of CAR-T cell therapy
By
Nick Paul Taylor
A CRISPR system that uses Cas13d to make reversible changes to the expression of multiple genes could overcome limitations that are holding back CAR-T cell therapies, a paper published in Cell suggests.
February 28, 2024
Intellia Therapeutics, ReCode Therapeutics to collaborate on genomic medicines for CF
By
LabPulse.com staff writers
Gene-editing firm Intellia Therapeutics and biotech company ReCode Therapeutics have entered into a strategic collaboration aimed at developing genomic medicines for the treatment of cystic fibrosis (CF).
February 16, 2024
CRISPR and nanopore technology enable sensitive and specific mpox detection
By
Nick Paul Taylor
A test that combines CRISPR gene editing and nanopore sensing technology could accelerate the detection of mpox and other pathogens, according to a paper published in
Biosensors and Bioelectronics
.
February 16, 2024
High hopes for accurate blood test detecting malignant brain tumors
By
Matt Limb
A simple blood test to detect malignant brain tumors that can be hard to locate could spare many cancer patients risky and invasive surgery, say scientists.
February 9, 2024
Twist Bioscience, Element Biosciences to collaborate on exome workflow
By
LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience and life science firm Element Biosciences have announced a collaboration to develop a dedicated workflow for Element’s AVITI system.
February 6, 2024
U.K. Health Security Agency unveils five-year pathogen genomics strategy
By
Matt Limb
The U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.
February 1, 2024
Blood test for Alzheimer’s shows high accuracy in study
By
Matt Limb
Scientists have hailed study results showing the high accuracy of a blood test that “could revolutionize” diagnosis of Alzheimer’s disease.
January 31, 2024
Jury awards Natera $96.3M in patent infringement case against CareDX
By
LabPulse.com staff writers
A jury in the U.S. District Court for the District of Delaware has ruled in favor of Natera in its patent infringement case against CareDx, awarding the firm approximately $96.3 million in damages in a unanimous verdict.
January 29, 2024
Researchers ID potential predictive biomarkers for CVD in type 2 diabetes
By
LabPulse.com staff writers
An analysis conducted by an international research team has identified 13 biomarkers that may improve the accuracy of predicting risk of cardiovascular disease (CVD) in people with type 2 diabetes.
January 25, 2024
Previous Page
Page 2 of 193
Next Page